For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220804:nRSD8492Ua&default-theme=true
RNS Number : 8492U MyHealthChecked PLC 04 August 2022
MyHealthChecked Plc
("MyHealthChecked" or the "Company")
Director/PDMR Shareholding
Non-Executive Chairman buys 1m shares
MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare
company, announces that it was notified that on 3 August 2022 Adam Reynolds,
Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary
shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7
pence per Ordinary Share.
Following this transaction, Adam Reynolds' total direct and indirect interest
in the Company is 10,513,293 Ordinary Shares representing approximately 1.35%
of the Group's total issued share capital.
The Notification of Dealing Form required in accordance with UK MAR is set out
below.
For further information contact:
MyHealthChecked plc www.myhealthchecked.com (http://www.myhealthchecked.com)
Penny McCormick, Chief Executive Officer via Walbrook PR
SPARK Advisory Partners Limited (NOMAD) Tel: +44 (0)20 3368 3550
Neil Baldwin
Oberon Capital Ltd (Broker) Tel: +44 (0)20 3179 5344
Mike Seabrook mikeseabrook@oberoninvestments.com (mailto:mikeseabrook@oberoninvestments.com)
Walbrook PR Ltd (Media & IR) Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
(mailto:myhealthcheckedplc@walbrookpr.com)
Paul McManus / Alice Woodings Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654
About MyHealthChecked PLC (www.myhealthcheckedplc.com
(http://www.myhealthcheckedplc.com) )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK
healthcare company focused on a range of at-home healthcare and wellness
tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests
that have been developed following the acquisition of The Genome Store in
November 2020. The tests are available online, and in some cases, for
over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in
mindset as customers become more familiar with the concept of accessible
healthcare in the growing at home testing kit market with a focus on
accessibility at the right price, led by UK-based experts.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities ("PDMRs") and persons closely associated ("PCA")
with them.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Adam Reynolds
2 Reason for the notification
a) Position/status Non-Executive Chairman
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name MYHEALTHCHECKED plc
b) LEI 213800RBHY6LZDG13168
CO4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares
Identification code ISIN: GB00BYZ2R301
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s)
Price(s) Volume(s)
1.7 pence 1,000,000
d) Aggregated information
- Aggregated volume N/A - Single Transaction
- Price
e) Date of the transaction 3 August 2022
f) Place of the transaction London Stock Exchange - AIMX
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHVXLFBLVLLBBZ